[EN] (2R, 5R)-6N-(1-IMINOETHYL)-2,6-DIAMINO-5-METHYL-4-THIOHEXANOIC ACID; SALTS THEREOF; A PROCESS FOR THEIR PREPARATION; PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN MEDECINE [FR] ACIDE (2R, 5R) - 6N- (1-IMINOETHYL)-2, 6-DIAMINO-5-METHYL-4-THIOHEXANOIQUE; SELS DE CE DERNIER, PROCEDE DE PREPARATION CORRESPONDANT; COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES ET UTILISATION DE CES DERNIERS EN MEDECINE
[EN] (2R, 5R)-6N-(1-IMINOETHYL)-2,6-DIAMINO-5-METHYL-4-THIOHEXANOIC ACID; SALTS THEREOF; A PROCESS FOR THEIR PREPARATION; PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN MEDECINE<br/>[FR] ACIDE (2R, 5R) - 6N- (1-IMINOETHYL)-2, 6-DIAMINO-5-METHYL-4-THIOHEXANOIQUE; SELS DE CE DERNIER, PROCEDE DE PREPARATION CORRESPONDANT; COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES ET UTILISATION DE CES DERNIERS EN MEDECINE
申请人:GLAXO GROUP LTD
公开号:WO2005005377A1
公开(公告)日:2005-01-20
ABSTRACT A process for making a medicinal vial in which a vial and a closure are moulded in parallel in respective vial and closure moulds, then the closure and vial are automatically assembled together, all in a sterile environment. An apparatus for performing this process is also provided. By the process and apparatus of the invention sealed vials with a sterile interior may be made
Development of a Supply Route for the Synthesis of an iNOS Inhibitor: Complications of the Key S<sub>N</sub>2 Reaction
作者:Geracimos Rassias、Stephen A. Hermitage、Mahesh J. Sanganee、Peter M. Kincey、Neil M. Smith、Ian P. Andrews、Gary T. Borrett、Graham R. Slater
DOI:10.1021/op900108b
日期:2009.7.17
The original medicinal chemistry synthesis of an iNOS inhibitor presented several challenges that had to be overcome in order to constitute a supply route suitable for operation on a multikilo scale. The key step in the synthesis is an S(N)2 reaction that assembles the chiral carbon framework, but this reaction proved far more complex than we anticipated. significant improvements were made to all stages. The modified route performed well over two pilot-plant campaigns and delivered over 250 kg of the active pharmaceutical ingredient (API).